DLH HOLDINGS CORP (DLHC) Stock Price & Overview

NASDAQ:DLHC • US23335Q1004

Current stock price

5.64 USD
-0.12 (-2.08%)
Last:

The current stock price of DLHC is 5.64 USD. Today DLHC is down by -2.08%. In the past month the price decreased by -3.59%. In the past year, price increased by 63.48%.

DLHC Key Statistics

52-Week Range2.72 - 8.1
Current DLHC stock price positioned within its 52-week range.
1-Month Range5.5001 - 6.25
Current DLHC stock price positioned within its 1-month range.
Market Cap
81.724M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.02
Dividend Yield
N/A

DLHC Stock Performance

Today
-2.08%
1 Week
-1.05%
1 Month
-3.59%
3 Months
+1.08%
Longer-term
6 Months +2.36%
1 Year +63.48%
2 Years -46.89%
3 Years -42.51%
5 Years -44.65%
10 Years +39.26%

DLHC Stock Chart

DLH HOLDINGS CORP / DLHC Daily stock chart

DLHC Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to DLHC. When comparing the yearly performance of all stocks, DLHC is one of the better performing stocks in the market, outperforming 83.5% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

DLHC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to DLHC. DLHC has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DLHC Earnings

On February 9, 2026 DLHC reported an EPS of -0.04 and a revenue of 68.89M. The company beat EPS expectations (43.98% surprise) and missed revenue expectations (-3.79% surprise).

Next Earnings DateMay 5, 2026
Last Earnings DateFeb 9, 2026
PeriodQ1 / 2026
EPS Reported-$0.04
Revenue Reported68.892M
EPS Surprise 43.98%
Revenue Surprise -3.79%

DLHC Forecast & Estimates

7 analysts have analysed DLHC and the average price target is 10.2 USD. This implies a price increase of 80.85% is expected in the next year compared to the current price of 5.64.

For the next year, analysts expect an EPS growth of -569.2% and a revenue growth -32.28% for DLHC


Analysts
Analysts82.86
Price Target10.2 (80.85%)
EPS Next Y-569.2%
Revenue Next Year-32.28%

DLHC Groups

Sector & Classification

DLHC Financial Highlights

Over the last trailing twelve months DLHC reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -104.55% compared to the year before.


Income Statements
Revenue(TTM)322.61M
Net Income(TTM)-1.08M
Industry RankSector Rank
PM (TTM) N/A
ROA -0.38%
ROE -0.96%
Debt/Equity 1.03
Chartmill High Growth Momentum
EPS Q2Q%-150%
Sales Q2Q%-24.11%
EPS 1Y (TTM)-104.55%
Revenue 1Y (TTM)-17.04%

DLHC Ownership

Ownership
Inst Owners67.55%
Shares14.49M
Float12.69M
Ins Owners12.42%
Short Float %0.34%
Short Ratio4.38

About DLHC

Company Profile

DLHC logo image DLH Holdings Corp. engages in the provision of health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. The company is headquartered in Atlanta, Georgia and currently employs 2,300 full-time employees. The firm is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The firm's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.

Company Info

IPO: 1986-05-29

DLH HOLDINGS CORP

3565 Piedmont Road, Ne, Building 3, Suite 700

Atlanta GEORGIA 30305 US

CEO: Zachary C. Parker

Employees: 2300

DLHC Company Website

DLHC Investor Relations

Phone: 18669521647

DLH HOLDINGS CORP / DLHC FAQ

What does DLHC do?

DLH Holdings Corp. engages in the provision of health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. The company is headquartered in Atlanta, Georgia and currently employs 2,300 full-time employees. The firm is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The firm's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.


What is the current price of DLHC stock?

The current stock price of DLHC is 5.64 USD. The price decreased by -2.08% in the last trading session.


What is the dividend status of DLH HOLDINGS CORP?

DLHC does not pay a dividend.


How is the ChartMill rating for DLH HOLDINGS CORP?

DLHC has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the Price/Earnings (PE) ratio of DLH HOLDINGS CORP (DLHC)?

DLH HOLDINGS CORP (DLHC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).


What is the market capitalization of DLHC stock?

DLH HOLDINGS CORP (DLHC) has a market capitalization of 81.72M USD. This makes DLHC a Micro Cap stock.